IN BRIEF: Faron Pharmaceuticals Chair Tuomo Patsi adds to shareholding

Related news

Faron Pharmaceuticals Ltd - Turku, Finland-based developer of cancer immunotherapies - Non-Executive Chair Tuomo Patsi buys 21,500 ordinary shares at €2.435 per share on Monday for a total of €52,353. Brings Patsi’s shareholding in Faron to 53,265 shares, with 0.05% of company voting rights.

Current stock price: 213.10p, up 5.2% on Wednesday in London

12-month change: More than doubled from 93.50p on July 2, 2024

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Directors

Ways to help you invest your money

Our investment accounts

Put your money to work with our range of investment accounts. Choose from ISAs, pensions, and more.

Need some investment ideas?

Let us give you a hand choosing investments. From managed funds to favourite picks, we’re here to help.

Read our expert tips and insights

Our investment experts share their knowledge on how to keep your money working hard across the markets.